COVID messaging: caring or condescending?
Research from the lab of Brian Carpenter, in Arts & Sciences, suggests older adults understood that sometimes-unflattering COVID-19 messaging came from a place of caring and compassion.
Before test results, signs of COVID-19 are in water systems
Research from the lab of Fangqiong Ling at the McKelvey School of Engineering finds SARS-CoV-2 material in wastewater reflects illnesses in communities. It also helps establish guidance for future studies.
WashU COVID-19 nasal vaccine technology licensed to Ocugen
Washington University has licensed the rights to develop, manufacture and commercialize its proprietary COVID-19 nasal vaccine in the United States, Europe and Japan to Ocugen Inc., a U.S.-based biotechnology company.
US has capacity to make essential drugs, study finds
The White House has sounded the alarm about vulnerabilities in the pharmaceutical supply chain. But new research from the Center for Analytics and Business Insights at Olin Business School found that the U.S. actually has the capacity to make the nation’s most essential and critical drugs — yet it’s mostly sitting idle.
How neighborhoods can protect — or harm — older adults’ cognitive health
People who lived in neighborhoods with ready access to civic and social organizations displayed higher cognitive scores than those who lived in neighborhoods with no immediate access to such organizations, finds a new study by researchers at Washington University in St. Louis and University of Michigan.
Sugarcane fires associated with mortality rates in South Florida
Research from a multi-institutional team, including Randall Martin at the McKelvey School of Engineering, estimated sugarcane fires in South Florida produce harmful emissions in quantities on par with vehicles — and play a role in the region’s mortality rates.
Ssewamala awarded $3.2M to study strategies for HIV treatments among Ugandan youth
Fred Ssewamala, the William E. Gordon Distinguished Professor at the Brown School, received a five-year $3.2 million grant from the National Institutes of Health to lead a study on intervention strategies for HIV treatments among Ugandan youth. The study could advance intervention science for HIV care globally.
World’s first nasal COVID-19 vaccine approved in India; based on Washington University technology
The world’s first nasal vaccine for COVID-19 was approved Sept. 6 in India for emergency use. The vaccine, called iNCOVACC, is based on technology licensed from Washington University and developed in collaboration with Bharat Biotech International Limited in India.
Faculty receive $6.1M NIH grant for maternal health study
Three faculty from the Brown School and School of Medicine at Washington University in St. Louis have received a seven-year $6.1 million grant from the National Institutes of Health (NIH) for a project aimed at improving the health of mothers and children in the St. Louis region.
Distress leads to higher COVID vaccine rates, less adherence to distancing guidelines
New research from the Department of Psychological & Brain Sciences in Arts & Sciences indicates that fear-based messaging may result in mixed effects when it comes to public health.
Older Stories